Buprenorphine Treatment Centers in Virginia

Adults with a clinical diagnosis of opioid use disorder (OUD) are eligible for buprenorphine treatment in Virginia. A licensed clinician confirms the diagnosis during intake using DSM-5 criteria, and the provider verifies identity and medical history before the first dose or injection.

Self-pay monthly cost for buprenorphine in Virginia typically ranges from $150 to $700, depending on medication, counseling intensity, and whether lab work is included. Long-acting injectables (Sublocade, Vivitrol) billed without insurance can exceed $1,500 per dose. Most patients pay far less through insurance or Cardinal Care.

Usually yes, if your provider is in-network with the new plan. Virginia MAT clinics typically contract with all major Cardinal Care managed-care organizations. Verify the provider’s network status before the effective date of your new plan to avoid interruption.

Yes. COBRA continues your former employer’s health plan unchanged for up to 18 months, including MAT benefits. The monthly COBRA premium is higher than a marketplace plan for most people; explore Marketplace options too before the 60-day COBRA deadline.

Yes. DEA rules were permanently expanded in 2024 to allow audio-video telehealth for initial buprenorphine prescribing, and Virginia law mirrors federal policy. Methadone induction still requires an in-person visit at an OTP for the first dose, though subsequent counseling can be delivered via telehealth. Naltrexone can be prescribed via telehealth with labs done in Virginia.

Yes. Meta-analyses consistently find that patients who remain on MAT longer than 12 months have lower rates of relapse, infectious disease, and overdose death. Virginia Medicaid-funded programs report improved retention with long-acting injectables compared to sublingual treatment.

Go to the nearest emergency department; Virginia hospitals are equipped to initiate buprenorphine and connect you to outpatient MAT. You can also call 988 for a live counselor to locate an open bridge clinic or mobile MAT unit.

Usually yes. Virginia programs following low-barrier protocols provide the first buprenorphine dose or naltrexone prescription on day one. Methadone first doses are administered in-clinic and require SAMHSA-certified protocols that are typically completed during the intake visit.

True allergic reactions to methadone, buprenorphine, or naltrexone are rare. Rash, swelling, or difficulty breathing after a dose should be treated as an emergency — call 911 or go to a Virginia emergency department. The MAT team can switch medications after stabilization.

Yes. Methadone and buprenorphine are the evidence-based standard of care in pregnancy, endorsed by ACOG and SAMHSA. Staying on MAT protects both mother and fetus; unmedicated withdrawal is riskier than continued MAT. Virginia providers coordinate care with obstetrics.

Sessions cover craving management, relapse-prevention skills, coping strategies, relationship issues, trauma processing if relevant, and goal setting for recovery. The counselor and client collaborate on a written treatment plan that is updated every 30–90 days in Virginia.

Yes, with proper documentation. Bring a letter from your Virginia MAT prescriber, medication in its original pharmacy container, and check destination-country rules — some countries restrict methadone and buprenorphine. The International Narcotics Control Board maintains destination-country guidance.